Very young women (<35 years) with operable breast cancer: features of disease at presentation. - Wikidata - wikimedia - TriplyDB

Very young women (<35 years) with operable breast cancer: features of disease at presentation.

Very young women (<35 years) with operable breast cancer: features of disease at presentation.

http://www.wikidata.org/entity/Q43910363

about

Young age: an independent risk factor for disease-free survival in women with operable breast cancer Triple negative breast cancer: looking for the missing link between biology and treatments Unique features of young age breast cancer and its management Vav3 oncogene is upregulated and a poor prognostic factor in breast cancer patients Retrospective analysis of clinicopathological characteristics and family history data of early-onset breast cancer: a single-institutional study of Hungarian patients.Breast cancer in young women: poor survival despite intensive treatment.Outcome after neoadjuvant chemotherapy in young breast cancer patients: a pooled analysis of individual patient data from eight prospectively randomized controlled trials.Being 40 or younger is an independent risk factor for relapse in operable breast cancer patients: the Saudi Arabia experience Breast carcinoma in young females below the age of 40 years: A histopathological perspective Distinct clinicopathological features and prognosis of emerging young-female breast cancer in an East Asian country: a nationwide cancer registry-based study.Breast cancer in moroccan young women: a retrospective study.Younger age is an independent predictor of worse prognosis among Lebanese nonmetastatic breast cancer patients: analysis of a prospective cohort.Establishment of a risk scoring system for predicting locoregional recurrence in T1 to T2 node-negative breast cancer patients treated with mastectomy: Implications for postoperative radiotherapy.Immunohistochemical prognostic index for breast cancer in young women.Preserving fertility in patients undergoing treatment for breast cancer: current perspectives.Breast cancer before age 40 years.Younger age as a prognostic indicator in breast cancer: a cohort study New Therapeutic Options for Breast Cancer during Pregnancy.Post-mastectomy radiotherapy can improve survival in breast cancer patients aged 35 years or younger with four or more positive nodes but not in one to three positive nodes.Effects of age on the detection and management of breast cancer.Comprehensive analysis of BRCA1, BRCA2 and TP53 germline mutation and tumor characterization: a portrait of early-onset breast cancer in Brazil.Risk factors and natural history of breast cancer in younger Chinese women.Breast cancer in young women Biology of breast cancer in young women.Fertility preservation and breast cancer: a review Breast cancer in 30-year-old or younger patients: clinicopathologic characteristics and prognosis.Benefits and adverse effects of endocrine therapy Luminal B subtype: a key factor for the worse prognosis of young breast cancer patients in China.Concurrent vs sequential adjuvant chemotherapy and hormone therapy in breast cancer: a multicenter randomized phase III trial.Impact of established prognostic factors and molecular subtype in very young breast cancer patients: pooled analysis of four EORTC randomized controlled trials Breast cancer in young women in southern Tunisia: Anatomical study and clinical prognostic factors: About a series of 83 patients.Biological characteristics and medical treatment of breast cancer in young women-a featured population: results from the NORA study.The expression of CXCL13 and its relation to unfavorable clinical characteristics in young breast cancer Comparison of Clinical Features and Treatment Outcome of Breast Cancers in Young and Elderly Chinese Patients Molecular Phenotype of Breast Cancer According to Time Since Last Pregnancy in a Large Cohort of Young Women.Tumor Invasiveness, Not Lymphangiogenesis, Is Correlated with Lymph Node Metastasis and Unfavorable Prognosis in Young Breast Cancer Patients (≤35 Years).Age of 40 years or younger is an independent risk factor for locoregional failure in early breast cancer: a single-institutional analysis in saudi arabia.The Effect of Young Age in Hormone Receptor Positive Breast Cancer.Prognostic effect analysis of molecular subtype on young breast cancer patients Breast cancer imaging: Mammography among women of up to 45 years.

P2860

Q24791855-850EFE5D-C585-4229-BDC8-2857035156EB Q26783122-1AAC151B-586F-4530-818B-20113DBBB3D1 Q26821902-334653F9-48AE-4911-83EE-0CAFE2AE8435 Q30384535-BF715D28-C818-446E-BC23-C13AB7F02ADD Q30633035-8414C040-F06A-451C-ACFD-D1EF579A58CC Q30882889-1E936A73-C480-494F-A238-62DFFD6BD902 Q30976616-176B0D7F-C1E6-41B2-B7C7-7BBD6AD47EAD Q33308326-A4676C35-BCBD-4F70-A74A-1D3E74D947B5 Q33584539-7F04BF05-154C-4EC8-98F1-F5AFB8D7C697 Q33699658-278C1443-6A1F-4340-A2DC-BA30BF104C69 Q33741050-D3EF17AC-F5B3-4840-9FB0-1FC9A63D5A07 Q33821156-3D50960E-469C-41CE-879C-724AF5ACD130 Q33879820-75AC85D0-7792-404C-BB3B-5A8161C22115 Q33919270-D79CFF52-0CD3-454F-8292-8E7397939FBB Q33939688-68DD7366-6D4A-400D-8304-DA8B9781577C Q33948726-B6BD9546-6799-4AEB-A6BE-13E8001912B1 Q34003908-5B7B496E-3A9F-4F86-802C-05D607230226 Q34096331-BAA0A299-F5D8-4C2F-90B4-22A52D035385 Q34351227-FEED3D3C-44FB-48A3-86CC-8C19E64DCF53 Q34477879-2D0F5BEB-8BF8-4FCF-8951-6DACB5CF6139 Q34613122-2AE5ED8E-9F00-47E3-B805-29EA51453091 Q34657634-B101269C-8152-4AE7-82D6-6ECDFC5D6B33 Q34989073-0967FF83-A5BD-436E-A737-78F794B218CE Q35000798-9EDB6290-839E-4448-A795-C0A0884CDACA Q35106163-6F49979F-8693-4835-8060-FFA4F93D8DD3 Q35127814-D5572801-64F0-450B-BACC-E60BE26F768D Q35135718-27634071-9417-409E-AA31-22FEAF2901F4 Q35319271-AABA1713-FD62-4185-9AE0-4C888BD92BF9 Q35460114-992640F1-4B2D-4ABA-B8E1-C7BADEF364BE Q35558130-CCB6D4F2-E172-4281-A734-517F678A4084 Q35566000-0FD48880-D9E0-4B45-904A-0E28E687E79D Q35746271-70E97FC3-E4DA-4B94-A072-1AA6F6C43545 Q35754593-72A30429-6715-4A80-AF56-1D12F4B8E570 Q35789382-387F1FD0-E385-48E2-AC43-516607F2C56B Q35820514-65DB1A09-FB1B-4BF9-998E-F6F3A87E68E6 Q35866159-26E5B254-4420-48C4-9E02-1E8FB62CF6F8 Q35876120-5B78CDEE-4B16-43B7-97B9-2683A25B09D3 Q36006184-53BC493F-1C62-4416-85A5-01999A655B0C Q36029962-74B7DDD8-1C79-4951-9EDF-8E2CCBAED3F2 Q36076619-4AB2022F-6C2D-4252-996D-92729196F2E7

P2860

Very young women (<35 years) with operable breast cancer: features of disease at presentation.

http://www.wikidata.org/entity/Q43910363

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Very young women (<35 years) w ...... es of disease at presentation.

@en

Very young women

@nl

type

label

Very young women (<35 years) w ...... es of disease at presentation.

@en

Very young women

@nl

prefLabel

Very young women (<35 years) w ...... es of disease at presentation.

@en

Very young women

@nl

P1433

Q43910363-EDAE29BE-4496-441B-91F4-CFDF2630A975

P1476

Q43910363-9F610939-BF23-40CD-A049-6405871BB422

P2093

Q43910363-0BF665F2-70D8-4AFF-8F8F-AA94C7EE08FD

Q43910363-159FCB3A-27F7-4A08-9EC0-FEC29FC54EA7

Q43910363-2A9F594B-18B1-4FDB-A2E7-B201763C0A0F

Q43910363-390D02AC-A3B4-4CA5-81B2-9BE7164E73FE

Q43910363-65C34DC5-6385-4922-881C-881BC65338E8

Q43910363-6828BBF4-070A-4C2C-A1A0-599DF16C018D

Q43910363-77635916-0567-47EC-8EEB-7B0A68EBF5C8

Q43910363-908D5A96-88C5-493E-8611-C60FA1812AC1

Q43910363-91D3079A-237A-48DC-A8FD-6EC9F1768EE5

Q43910363-9207ECFE-9773-4650-AE77-41F4CA89BE70

P2860

Q43910363-124F6C70-BC66-4A97-9866-A45965083E7B

Q43910363-15710236-4D99-400C-B48C-92C5A994B0F5

Q43910363-2130B641-9AAE-41AF-89EC-775D21DECE76

Q43910363-267BCAF8-6D2D-465B-81BA-94D34CE09F74

Q43910363-43FAD1A5-3F98-4E2C-8B41-404718A4E5DC

Q43910363-50F02439-24BD-4797-91F5-5C5CD1CF6E11

Q43910363-63B187FB-6866-43C2-8ED7-8349529B2EE9

Q43910363-71AF4DF6-1CA9-4519-8CD5-120A3D55FA11

Q43910363-7D3D33E2-3856-41B5-9F10-D435BB06D844

Q43910363-8EB35E4F-BBAC-4040-90FD-8B81E6F5C2ED

P304

Q43910363-009A9530-BB46-4052-B41E-DEB9F2C71B03

P31

Q43910363-AACAEAB5-6BAD-4E57-B68C-13150469D47C

P356

Q43910363-A3388F16-193A-4D4B-871A-19D024099A1F

P433

Q43910363-2E7FD5A8-E53C-4C63-95F3-B0E1B25A9C00

P478

Q43910363-90CEBE77-D13A-471E-9AB2-4FFFD486AE67

P50

Q43910363-AB196348-094D-4C27-B4C9-88D6106B38FC

P577

Q43910363-FD7A7C37-4DAB-4B20-AD1D-E3DCE25B6E3E

P5875

Q43910363-4A5077B3-6BDB-4B93-AE39-DF1ED56F7DED

P698

Q43910363-42046CD1-78BE-4B3A-8538-3A64FB3833A4

P356

P1433

Annals of Oncology

P1476

Very young women (<35 years) w ...... res of disease at presentation

@en

P2093

A Goldhirsch

http://www.w3.org/2001/XMLSchema#string

A Luini

http://www.w3.org/2001/XMLSchema#string

C Robertson

http://www.w3.org/2001/XMLSchema#string

F Nolé

http://www.w3.org/2001/XMLSchema#string

G Catalano

http://www.w3.org/2001/XMLSchema#string

G Martinelli

http://www.w3.org/2001/XMLSchema#string

G Renne

http://www.w3.org/2001/XMLSchema#string

G Viale

http://www.w3.org/2001/XMLSchema#string

L Orlando

http://www.w3.org/2001/XMLSchema#string

M Intra

http://www.w3.org/2001/XMLSchema#string

P2860

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer.

Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?

Factors predicting treatment responsiveness and prognosis in node-negative breast cancer. The International (Ludwig) Breast Cancer Study Group.

Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival.

Breast carcinomas occurring in young women (< 35 years) are different.

Early-onset breast cancer--histopathological and prognostic considerations

Risk-group discrimination in node-negative breast cancer using invasion and proliferation markers: 6-year median follow-up.

The National Cancer Data Base report on breast carcinoma characteristics and outcome in relation to age.

HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas.

P304

273-279

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/ANNONC/MDF039

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

P577

2002-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

245765754

http://www.w3.org/2001/XMLSchema#string

P698

11886005

http://www.w3.org/2001/XMLSchema#string